SCRUTINIZERS REPORT FOR THE EGM HELD ON 11TH MAY 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Beryl Drugs Ltd held an Extra-Ordinary General Meeting on 11th May 2026 where three ordinary resolutions were passed unanimously. Resolution 1 regularised the appointment of Mr. Shailendra Pathak as Whole Time Director. Resolution 2 appointed Mrs. Neha Sarda as Non-Executive Independent Director. Resolution 3 approved a material related party transaction with M/S. Aminova Infusions P. Ltd. Voting was conducted via remote e-voting (8th-10th May) and poll at the EGM. Out of 5,071,700 total shares, 1,683,633 votes (33.19%) were polled, with 100% in favour and zero votes against for all resolutions.
All resolutions passed smoothly with unanimous shareholder support, indicating no shareholder opposition to the director appointments or the related party transaction. The low voter turnout (33.19%) is typical for small-cap companies where promoter holdings are high.